ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $627,263 | -17.9% | 30,099 | -5.6% | 0.01% | -16.7% |
| Q2 2023 | $763,933 | +15.3% | 31,897 | -9.4% | 0.01% | 0.0% |
| Q1 2023 | $662,276 | +21.5% | 35,190 | +2.7% | 0.01% | +20.0% |
| Q4 2022 | $545,276 | +1.4% | 34,251 | +4.1% | 0.01% | -16.7% |
| Q3 2022 | $538,000 | +17.0% | 32,901 | +0.7% | 0.01% | +50.0% |
| Q2 2022 | $460,000 | -41.7% | 32,674 | +0.3% | 0.00% | -33.3% |
| Q1 2022 | $789,000 | +4.2% | 32,591 | +0.5% | 0.01% | 0.0% |
| Q4 2021 | $757,000 | +39.2% | 32,427 | -0.9% | 0.01% | +50.0% |
| Q3 2021 | $544,000 | -31.7% | 32,724 | +0.3% | 0.00% | -33.3% |
| Q2 2021 | $796,000 | -11.1% | 32,629 | -6.0% | 0.01% | -25.0% |
| Q1 2021 | $895,000 | -51.5% | 34,709 | +0.5% | 0.01% | -52.9% |
| Q4 2020 | $1,847,000 | +26.9% | 34,551 | -2.0% | 0.02% | +21.4% |
| Q3 2020 | $1,455,000 | +14.1% | 35,270 | +34.1% | 0.01% | -22.2% |
| Q2 2020 | $1,275,000 | +11.3% | 26,296 | -3.0% | 0.02% | -10.0% |
| Q1 2020 | $1,146,000 | – | 27,120 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |